Patent details

Basic Information

Publication number:

LUC00014

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP100109974

Legal Status:

Active

Application number:

LUC00014

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/923

Marketing Authorization Type:

Marketing Authorization Date:

27/05/2014

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

11/04/2017

First Marketing Authorization date:

27/05/2014

Grant date:

19/06/2017

Activation date:

13/04/2021

Publication date:

18/04/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

13/04/2026

SPC Extension Expiration:

13/04/2026

Rejection date:

Withdrawal date:

Owner

From:

22/12/2021

 

 

Name:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Address:

1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

From:

11/04/2017

 

 

Name:

Genentech Inc.

Address:

1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

History of Owners

From:

11/04/2017

To:

22/12/2021

Name:

Millennium Pharmaceuticals Inc.

Address:

40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Agent

Name:

KIRKPATRICK

From:

11/04/2017

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2017/02

Publication date:

22/06/2017

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:

SPC3

Bulletin edition number:

2021/06

Publication date:

04/05/2021

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

4

Bulletin Heading:

CO

Bulletin edition number:

2022/01

Publication date:

03/01/2022

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20210000533A

Date Registered:

22/12/2021

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

KIRKPATRICK

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Address:

1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

2

Name:

Genentech Inc.

Address:

1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

28/04/2025

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

KIRKPATRICK SA / NV

Filing date	Document type	Number of pages
23/12/2021	Outgoing Correspondence	1
11/04/2017	General Document	5
11/04/2017	General Document	11
11/04/2017	General Document	36
18/04/2017	Outgoing Correspondence	1
11/04/2017	Incoming Correspondence (Post)	2
11/04/2017	Application Form	4
22/12/2021	Request For Change	7
11/04/2017	General Document	11
18/04/2017	Publication	1